Literature DB >> 19844779

Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome.

Elham Barkhordari1, Nima Rezaei, Bita Ansaripour, Pegah Larki, Maryam Alighardashi, Hamid Reza Ahmadi-Ashtiani, Mahdi Mahmoudi, Mohammad-Reza Keramati, Peiman Habibollahi, Mohammad Bashashati, Naser Ebrahimi-Daryani, Ali Akbar Amirzargar.   

Abstract

INTRODUCTION: Irritable bowel syndrome (IBS) is a multifactorial functional gastrointestinal disorder, characterized by recurrent abdominal pain and altered bowel habits. Proinflammatory cytokines can play an important role in intestinal inflammation, while their production is under genetic control.
METHODS: This study was performed in a group of patients with IBS to analyze the genotype frequencies of a number polymorphic genes coding for proinflammatory cytokine (interleukin-6 (IL), tumor necrosis factor-alpha (TNF-alpha), and IL-1 group). Using polymerase chain reaction with sequence-specific primers method, the cytokine genes were amplified, and alleles and genotypes of 71 patients with IBS were detected on gel electrophoresis, and the results were compared with healthy control subjects.
RESULTS: Results of the analyzed data showed that the frequencies IL-1R C allele at position Pst-I 1970 (P = 0.017), IL-6 G allele at position -174 (P = 0.002), and TNF-alpha G allele at position -238 (P < 0.001) in the patient group were significantly higher than the control group. IL-6 GG genotype (-174) and TNF-alpha GG genotype (-238) in the patient group were also significantly overrepresented (P < 0.001), while IL-6 CG genotype (-174) and TNF-alpha GA genotype (-238) were significantly decreased in the patients with IBS (P < 0.001). The frequencies of IL-6 (-174, nt565) GG haplotype and TNF-alpha (-308, -238) GG haplotype were also significantly higher in the patient group (P < 0.001), whereas the frequencies of the haplotypes IL-6 CG and TNF-alpha GA were significantly decreased in the patients with IBS (P < 0.001).
CONCLUSION: IL-6 and TNF-alpha proinflammatory cytokine gene polymorphisms could change individual susceptibility to IBS and might have a role in pathophysiology of disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19844779     DOI: 10.1007/s10875-009-9342-4

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  35 in total

1.  Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis.

Authors:  Ali Akbar Amirzargar; Nima Rezaei; Hossein Jabbari; Abdol-Ali Danesh; Farideh Khosravi; Mahboubeh Hajabdolbaghi; Alireza Yalda; Behrouz Nikbin
Journal:  Eur Cytokine Netw       Date:  2006-06       Impact factor: 2.737

2.  Cytokine single nucleotide polymorphisms in Iranian populations.

Authors:  Ali Akbar Amirzargar; Mehrnaz Naroueynejad; Farideh Khosravi; Seyed Saied Dianat; Saied Dianat; Nima Rezaei; Joannis Mytilineos; Behrouz Nikbin
Journal:  Eur Cytokine Netw       Date:  2008-06-01       Impact factor: 2.737

Review 3.  Functional bowel disorders and functional abdominal pain.

Authors:  W G Thompson; G F Longstreth; D A Drossman; K W Heaton; E J Irvine; S A Müller-Lissner
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

4.  IL-1beta and TNF-alpha, but not IFN-alpha, IFN-gamma, IL-6 or IL-8, are secretory mediators in human distal colon.

Authors:  H Bode; H Schmitz; M Fromm; P Scholz; E O Riecken; J D Schulzke
Journal:  Cytokine       Date:  1998-06       Impact factor: 3.861

5.  Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes.

Authors:  S C Hoffmann; E M Stanley; E Darrin Cox; N Craighead; B S DiMercurio; D E Koziol; D M Harlan; A D Kirk; P J Blair
Journal:  Transplantation       Date:  2001-10-27       Impact factor: 4.939

Review 6.  The genetics of irritable bowel syndrome.

Authors:  Yuri A Saito; Gloria M Petersen; G Richard Locke; Nicholas J Talley
Journal:  Clin Gastroenterol Hepatol       Date:  2005-11       Impact factor: 11.382

7.  Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency.

Authors:  N Rezaei; A A Amirzargar; Y Shakiba; M Mahmoudi; B Moradi; A Aghamohammadi
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

8.  Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55.

Authors:  H Tilg; E Trehu; M B Atkins; C A Dinarello; J W Mier
Journal:  Blood       Date:  1994-01-01       Impact factor: 22.113

Review 9.  Genetic determination of irritable bowel syndrome.

Authors:  Cristina Hotoleanu; Radu Popp; Adrian-Pavel Trifa; Laurentiu Nedelcu; Dan-L Dumitrascu
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

10.  Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome.

Authors:  T Lembo; J Munakata; H Mertz; N Niazi; A Kodner; V Nikas; E A Mayer
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

View more
  27 in total

1.  Findings related to IL-8 and IL-10 gene polymorphisms in a Mexican patient population with irritable bowel syndrome infected with Blastocystis.

Authors:  Angelica Olivo-Diaz; Mirza Romero-Valdovinos; Areli Gudiño-Ramirez; Jesus Reyes-Gordillo; Diego Emiliano Jimenez-Gonzalez; Maria Elena Ramirez-Miranda; Williams Arony Martinez-Flores; Fernando Martinez-Hernandez; Ana Flisser; Pablo Maravilla
Journal:  Parasitol Res       Date:  2012-07       Impact factor: 2.289

2.  High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome.

Authors:  Keren Hod; Tamar Ringel-Kulka; Christopher F Martin; Nitsan Maharshak; Yehuda Ringel
Journal:  J Clin Gastroenterol       Date:  2016-03       Impact factor: 3.062

3.  Excess risk of temporomandibular disorder associated with cigarette smoking in young adults.

Authors:  Anne E Sanders; William Maixner; Andrea G Nackley; Luda Diatchenko; Kunthel By; Vanessa E Miller; Gary D Slade
Journal:  J Pain       Date:  2011-10-26       Impact factor: 5.820

Review 4.  Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome.

Authors:  Yehuda Ringel; Nitsan Maharshak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-07-25       Impact factor: 4.052

5.  Blastocystis infection is associated with irritable bowel syndrome in a Mexican patient population.

Authors:  Diego Emiliano Jimenez-Gonzalez; Williams Arony Martinez-Flores; Jesus Reyes-Gordillo; Maria Elena Ramirez-Miranda; Sara Arroyo-Escalante; Mirza Romero-Valdovinos; Damien Stark; Valeria Souza-Saldivar; Fernando Martinez-Hernandez; Ana Flisser; Angelica Olivo-Diaz; Pablo Maravilla
Journal:  Parasitol Res       Date:  2011-08-26       Impact factor: 2.289

6.  Salmeterol attenuates the inflammatory response in asthma and decreases the pro-inflammatory cytokine secretion of dendritic cells.

Authors:  Zhenli Hu; Ruohua Chen; Zhijian Cai; Lei Yu; Yang Fei; Lixia Weng; Jinghan Wang; Xiahui Ge; Tianyi Zhu; Jianli Wang; Chong Bai
Journal:  Cell Mol Immunol       Date:  2012-01-09       Impact factor: 11.530

7.  Malassezia Yeast and Cytokine Gene Polymorphism in Atopic Dermatitis.

Authors:  Charu Jain; Shukla Das; V G Ramachandran; Rumpa Saha; S N Bhattacharya; Sajad Dar
Journal:  J Clin Diagn Res       Date:  2017-03-01

Review 8.  Molecular basis of the irritable bowel syndrome.

Authors:  Anna Vaiopoulou; Georgios Karamanolis; Theodora Psaltopoulou; George Karatzias; Maria Gazouli
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

9.  Interleukin-8 and -10 gene polymorphisms in irritable bowel syndrome.

Authors:  Mirza Romero-Valdovinos; Areli Gudiño-Ramírez; Jesús Reyes-Gordillo; Williams Arony Martínez-Flores; María Elena Ramírez-Miranda; Pablo Maravilla; Angélica Olivo-Díaz
Journal:  Mol Biol Rep       Date:  2012-06-28       Impact factor: 2.316

Review 10.  Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy.

Authors:  Massimo Bellini; Dario Gambaccini; Cristina Stasi; Maria Teresa Urbano; Santino Marchi; Paolo Usai-Satta
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.